NEW YORK , June 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
LOS ANGELES , June 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) have opportunity to lead the securities fraud class action lawsuit.
NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.
![]() WST In 1 month Announced | Quarterly | $0.21 Per Share |
![]() WST 1 month ago Paid | Quarterly | $0.21 Per Share |
![]() WST 4 months ago Paid | Quarterly | $0.21 Per Share |
![]() WST 7 months ago Paid | Quarterly | $0.21 Per Share |
![]() WST 10 months ago Paid | Quarterly | $0.2 Per Share |
23 Jul 2025 (32 Days) Date | | - Cons. EPS | - EPS |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
13 Feb 2025 Date | | 1.71 Cons. EPS | 1.82 EPS |
24 Oct 2024 Date | | 1.5 Cons. EPS | 1.85 EPS |
25 Jul 2024 Date | | 1.74 Cons. EPS | 1.52 EPS |
![]() WST In 1 month Announced | Quarterly | $0.21 Per Share |
![]() WST 1 month ago Paid | Quarterly | $0.21 Per Share |
![]() WST 4 months ago Paid | Quarterly | $0.21 Per Share |
![]() WST 7 months ago Paid | Quarterly | $0.21 Per Share |
![]() WST 10 months ago Paid | Quarterly | $0.2 Per Share |
23 Jul 2025 (32 Days) Date | | - Cons. EPS | - EPS |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
13 Feb 2025 Date | | 1.71 Cons. EPS | 1.82 EPS |
24 Oct 2024 Date | | 1.5 Cons. EPS | 1.85 EPS |
25 Jul 2024 Date | | 1.74 Cons. EPS | 1.52 EPS |
Medical - Instruments & Supplies Industry | Healthcare Sector | Mr. Eric M. Green CEO | XMUN Exchange | US9553061055 ISIN |
US Country | 10,600 Employees | 30 Apr 2025 Last Dividend | 27 Sep 2013 Last Split | 13 Jan 1978 IPO Date |